Critical illnesses have a significant impact on overall survival among patients with cancer
the ONA take:
A new study from researchers at the University of Glasgow found 1 in 20 patients with cancer were admitted to the intensive care unit (ICU) for a critical illness within 2 years of their diagnosis, and a quarter of them died in hospital. In addition, this risk increased with age.
Using cancer registry and hospital data from Scotland spanning 10 years, the researchers captured information on more than 118,500 people with cancer, including 6,116 who were admitted to ICU.
Study findings showed that risk of ICU admission was highest among patients with GI cancer and lowest in patients with prostate cancer, breast cancer, and melanoma of the skin.
Mortality was higher among emergency medical admissions, and those who received organ support compared with those who did not receive organ support.
Deaths during hospital stays was higher among patients with cancers of unknown primary cause, lung cancer, and liver cancer, but those with head and neck cancers, multiple cancers, kidney cancer, and thyroid cancer had lower mortality rates.
The study indicates that critical illness may play a role in overall cancer outcomes. The researchers suggest that if ICUs can effectively reduce the risk of dying following a critical illness, increased surveillance for early signs of critical illness and access to ICU care for patients with cancer may improve overall survival rates.
1 in 20 patients with cancer were admitted to the intensive care unit (ICU) for a critical illness within 2 years of their diagnosis.
Sign Up for Free e-newsletters
- Evolution of HER2-Positive Breast Cancer: Yesterday, Today, and Tomorrow
- Scalp Cooling With Dignicap May Reduce Alopecia During Chemotherapy for Breast Cancer
- Dedicated End-of-Life Education Program Improves Nurses' Care, Patient and Family Satisfaction
- Oncology Extended Care Clinic Reduced Urgent Cancer-Related ED Visits
- Cervical Cancer Outcomes Comparable With Adjuvant Chemotherapy, Chemoradiotherapy
- Hair Dyes and Cancer Risk (Fact Sheet)
- Taste Changes After Hematopoietic Stem Cell Transplant Affect QOL in Blood Cancers
- Hope, Optimism Reduce Psychological Distress in Advanced Cancer
- Risk for Long-Term Cardiovascular Disease Increased for Endometrial Cancer Survivors
- Mitomycin Extravasation Protocol
- Nursing Practice Change Improved Chemo Administration, But Old Habits Die Hard
- Simple Adjustment Key to Paclitaxel Infusion Protocol That Reduced Hypersensitivity Reactions
- Online Program Aims to Assist With Clinical Trial Enrollment for Hematologic Cancers
- Education May Better Equip Nurses to Hold End-of-Life Conversations in Advanced Cancer
- Skipping the SICU Post Head and Neck Cancer Surgery May Improve Outcomes
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|